Lataa...

ISS-Ⅲ期伴1q扩增或17p缺失双重打击初诊多发性骨髓瘤患者的预后分析

OBJECTIVE: To evaluate the prognostic significance of combining ISS-Ⅲ and high risk cytogenetic abnormalities [HRCAs, including 1q gain/amplification and del (17p) ] in patients with newly-diagnosed multiple myeloma (NDMM) . METHODS: The clinical characteristics and relevant variables were retrospec...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Zhonghua Xue Ye Xue Za Zhi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Editorial office of Chinese Journal of Hematology 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7342365/
https://ncbi.nlm.nih.gov/pubmed/31856439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.11.005
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!